Lorraine V. Kalia

NMDA receptors in clinical neurology: excitatory times ahead.

Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).

Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly.

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

α-Synuclein and Lewy pathology in Parkinson's disease.

Disease-modifying strategies for Parkinson's disease.

Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease.

α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.

α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Animal models of α-synucleinopathy for Parkinson disease drug development.

Biomarkers for cognitive dysfunction in Parkinson's disease.

Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Complex genomic rearrangement in SPG11 due to a DNA replication-based mechanism.

Is there a role for MR-guided focused ultrasound in Parkinson's disease?

Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease.

Tremor in Spinocerebellar Ataxia Type 12.

Parkinsonism due to A53E α-synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features.

Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid.

Deep brain stimulation: potential for neuroprotection.

The clinical significance of lower limb tremors.

Multiple system atrophy and myoclonus: A morphologic marker in the spinal cord?

Expert comment: "A case of missing pathology in a patient with LRRK2 Parkinson's disease".

Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death.

Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein.

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease.

Deep Brain Stimulation of the Medial Septal Nucleus Induces Expression of a Virally Delivered Reporter Gene in Dentate Gyrus.

LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?

Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson's disease.

Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members.

The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates.

C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside

The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates.

AN INTELLIGENT DIAGNOSIS: SMART SYNDROME.